MagnetisMM-5

Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (MAGNETISMM-5)

Near Add Your Location

Sorting 14 by

Sylvester Comprehensive Cancer Center
University of Miami
Coral Gables, FL
  • Accepting patients
Sylvester Comprehensive Cancer Center
University of Miami
Deerfield Beach, FL
  • Accepting patients
Memorial Sloan Kettering Nassau
Uniondale, NY
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.